Trichomegaly
|
0.400 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Cataract
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Long eyelashes
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Osteosarcoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
<b>Results:</b> FGF5 was significantly upregulated in OS tissues and cells, and closely associated with poor differentiation, larger tumor size, lymph node metastasis, and advanced TNM stage.
|
31372048 |
2019 |
Osteosarcoma of bone
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
<b>Results:</b> FGF5 was significantly upregulated in OS tissues and cells, and closely associated with poor differentiation, larger tumor size, lymph node metastasis, and advanced TNM stage.
|
31372048 |
2019 |
Childhood Osteosarcoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
<b>Results:</b> FGF5 was significantly upregulated in OS tissues and cells, and closely associated with poor differentiation, larger tumor size, lymph node metastasis, and advanced TNM stage.
|
31372048 |
2019 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
<b>Results:</b> FGF5 was significantly upregulated in OS tissues and cells, and closely associated with poor differentiation, larger tumor size, lymph node metastasis, and advanced TNM stage.
|
31372048 |
2019 |
Fibrosis, Liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
FGF5 and a high-fat diet play significant roles in the pathophysiology of hepatic fibrosis and Fgf5 null mice may provide a suitable model for liver fibrosis or NASH.
|
24521867 |
2014 |
Fatty Liver Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
FGF5 and a high-fat diet play significant roles in the pathophysiology of hepatic fibrosis and Fgf5 null mice may provide a suitable model for liver fibrosis or NASH.
|
24521867 |
2014 |
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
FGF5 is expressed in melanoma and enhances malignancy <i>in vitro</i> and <i>in vivo</i>.
|
29152117 |
2017 |
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
FGF5 is expressed in melanoma and enhances malignancy <i>in vitro</i> and <i>in vivo</i>.
|
29152117 |
2017 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
FGF-5 was found to be expressed in the neonatal brain and in 3 of the 13 human tumor cell lines examined.
|
3211147 |
1988 |
Steatohepatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
After consumption of a high fat diet (HFD) for 8 weeks, FGF5 null mice developed severe steatohepatitis and fibrosis resembling human NASH.
|
27708340 |
2016 |
Fatty Liver Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
After consumption of a high fat diet (HFD) for 8 weeks, FGF5 null mice developed severe steatohepatitis and fibrosis resembling human NASH.
|
27708340 |
2016 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
As a normal protein with significant overexpression by multiple adenocarcinomas and little normal tissue expression, FGF-5 represents an immunotherapy target with potential utility against a broad array of nonmelanoma cancers.
|
11454700 |
2001 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
BC patients in the FGF5 low-expression group were correlated with better clinical characteristics, including tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, NPI criteria and Veridex signature, DMFS, TDM, and DFS compared with those in the FGF5 high-expression cohort.
|
29804124 |
2018 |
Atrial Fibrillation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.
|
30061737 |
2018 |
Paroxysmal atrial fibrillation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.
|
30061737 |
2018 |
Persistent atrial fibrillation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.
|
30061737 |
2018 |
familial atrial fibrillation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.
|
30061737 |
2018 |
Acquired Immunodeficiency Syndrome
|
0.010 |
Biomarker
|
group |
BEFREE |
Biopsy samples from five acquired immune deficiency syndrome (AIDS)-Kaposi's sarcomas and one non-AIDS-associated Kaposi's sarcoma were assayed by in situ RNA hybridization onto paraformaldehyde-fixed, paraffin-embedded skin sections for the presence of two fibroblast growth factor gene transcripts, FGFB and FGF5.
|
1987771 |
1991 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
CONCLUSIONS Our results suggest that FGF5 is an independent protective factor for BC patients.
|
29804124 |
2018 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
CONCLUSIONS Our results suggest that FGF5 is an independent protective factor for BC patients.
|
29804124 |
2018 |
Alopecia, Male Pattern
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |
Other alopecia
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |